APO RESEARCH · REPORT
Dry Eye Drugs
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Product & engineering
Understand the product.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Selected research
Industry Research
Dry Eye Drugs Industry Research Report 2026
Market perspective
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
Read the full market overview
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
Report Scope
This report quantifies the global Dry Eye Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dry Eye Drugs Market by Company
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Dry Eye Drugs Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Dry Eye Drugs Segment by Application
Hospital
Drug Stores
Online Pharmacies
Dry Eye Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dry Eye Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dry Eye Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Anti-inflammatory Drugs
- Other
Applications
- Hospital
- Drug Stores
- Online Pharmacies
Companies covered
- Allergan
- Novartis AG
- Bausch Health
- Santen Pharma
- Takeda
- Johnson & Johnson
- United Laboratories
- Senju Pharmaceutical
- Jianfeng Group
- Eusan GMBH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dry Eye Drugs Market Size (2021-2032)
- 2.2.2 Global Dry Eye Drugs Sales (2021-2032)
- 2.2.3 Global Dry Eye Drugs Market Average Price (2021-2032)
- 2.3 Dry Eye Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Artificial Tears
- 2.3.3 Anti-inflammatory Drugs
- 2.3.4 Other
- 2.4 Dry Eye Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Stores
- 2.4.4 Online Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dry Eye Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dry Eye Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Dry Eye Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Dry Eye Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Dry Eye Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dry Eye Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dry Eye Drugs, Product Type & Application
- 3.8 Global Manufacturers of Dry Eye Drugs, Established Date
- 3.9 Global Dry Eye Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Allergan
- 4.1.1 Allergan Company Information
- 4.1.2 Allergan Business Overview
- 4.1.3 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Allergan Dry Eye Drugs Product Portfolio
- 4.1.5 Allergan Recent Developments
- 4.2 Novartis AG
- 4.2.1 Novartis AG Company Information
- 4.2.2 Novartis AG Business Overview
- 4.2.3 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis AG Dry Eye Drugs Product Portfolio
- 4.2.5 Novartis AG Recent Developments
- 4.3 Bausch Health
- 4.3.1 Bausch Health Company Information
- 4.3.2 Bausch Health Business Overview
- 4.3.3 Bausch Health Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bausch Health Dry Eye Drugs Product Portfolio
- 4.3.5 Bausch Health Recent Developments
- 4.4 Santen Pharma
- 4.4.1 Santen Pharma Company Information
- 4.4.2 Santen Pharma Business Overview
- 4.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Santen Pharma Dry Eye Drugs Product Portfolio
- 4.4.5 Santen Pharma Recent Developments
- 4.5 Takeda
- 4.5.1 Takeda Company Information
- 4.5.2 Takeda Business Overview
- 4.5.3 Takeda Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Takeda Dry Eye Drugs Product Portfolio
- 4.5.5 Takeda Recent Developments
- 4.6 Johnson & Johnson
- 4.6.1 Johnson & Johnson Company Information
- 4.6.2 Johnson & Johnson Business Overview
- 4.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Johnson & Johnson Dry Eye Drugs Product Portfolio
- 4.6.5 Johnson & Johnson Recent Developments
- 4.7 United Laboratories
- 4.7.1 United Laboratories Company Information
- 4.7.2 United Laboratories Business Overview
- 4.7.3 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 United Laboratories Dry Eye Drugs Product Portfolio
- 4.7.5 United Laboratories Recent Developments
- 4.8 Senju Pharmaceutical
- 4.8.1 Senju Pharmaceutical Company Information
- 4.8.2 Senju Pharmaceutical Business Overview
- 4.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Senju Pharmaceutical Dry Eye Drugs Product Portfolio
- 4.8.5 Senju Pharmaceutical Recent Developments
- 4.9 Jianfeng Group
- 4.9.1 Jianfeng Group Company Information
- 4.9.2 Jianfeng Group Business Overview
- 4.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jianfeng Group Dry Eye Drugs Product Portfolio
- 4.9.5 Jianfeng Group Recent Developments
- 4.10 Eusan GMBH
- 4.10.1 Eusan GMBH Company Information
- 4.10.2 Eusan GMBH Business Overview
- 4.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Eusan GMBH Dry Eye Drugs Product Portfolio
- 4.10.5 Eusan GMBH Recent Developments
5 Global Dry Eye Drugs Market Scenario by Region
- 5.1 Global Dry Eye Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dry Eye Drugs Sales by Region: 2021-2032
- 5.2.1 Global Dry Eye Drugs Sales by Region: 2021-2026
- 5.2.2 Global Dry Eye Drugs Sales by Region: 2027-2032
- 5.3 Global Dry Eye Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Dry Eye Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Dry Eye Drugs Revenue by Region: 2027-2032
- 5.4 North America Dry Eye Drugs Market Facts & Figures by Country
- 5.4.1 North America Dry Eye Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dry Eye Drugs Sales by Country (2021-2032)
- 5.4.3 North America Dry Eye Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dry Eye Drugs Market Facts & Figures by Country
- 5.5.1 Europe Dry Eye Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dry Eye Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Dry Eye Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dry Eye Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dry Eye Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dry Eye Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dry Eye Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dry Eye Drugs Market Facts & Figures by Country
- 5.7.1 South America Dry Eye Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dry Eye Drugs Sales by Country (2021-2032)
- 5.7.3 South America Dry Eye Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dry Eye Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dry Eye Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dry Eye Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dry Eye Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dry Eye Drugs Sales by Type (2021-2032)
- 6.1.1 Global Dry Eye Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Dry Eye Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Dry Eye Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Dry Eye Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dry Eye Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Dry Eye Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dry Eye Drugs Sales by Application (2021-2032)
- 7.1.1 Global Dry Eye Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Dry Eye Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Dry Eye Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Dry Eye Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dry Eye Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Dry Eye Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dry Eye Drugs Value Chain Analysis
- 8.1.1 Dry Eye Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dry Eye Drugs Production Mode & Process
- 8.2 Dry Eye Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dry Eye Drugs Distributors
- 8.2.3 Dry Eye Drugs Customers
9 Global Dry Eye Drugs Analyzing Market Dynamics
- 9.1 Dry Eye Drugs Industry Trends
- 9.2 Dry Eye Drugs Industry Drivers
- 9.3 Dry Eye Drugs Industry Opportunities and Challenges
- 9.4 Dry Eye Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst